vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
American Healthcare REIT, Inc. is the larger business by last-quarter revenue ($564.0M vs $339.0M, roughly 1.7× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 13.2% vs 1.9%, a 11.3% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -2.7%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 0.4%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AHR vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $339.0M |
| Net Profit | $10.8M | $44.7M |
| Gross Margin | 14.8% | 59.7% |
| Operating Margin | 19.8% | 19.9% |
| Net Margin | 1.9% | 13.2% |
| Revenue YoY | 13.5% | -2.7% |
| Net Profit YoY | 133.9% | 19.3% |
| EPS (diluted) | $0.07 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $339.0M | ||
| Q3 25 | $532.1M | $327.3M | ||
| Q2 25 | $501.3M | $321.4M | ||
| Q1 25 | $497.2M | $330.6M | ||
| Q4 24 | $496.8M | $348.5M | ||
| Q3 24 | $476.8M | $345.5M | ||
| Q2 24 | $458.0M | $336.2M | ||
| Q1 24 | $452.1M | — |
| Q4 25 | $10.8M | $44.7M | ||
| Q3 25 | $55.9M | $38.7M | ||
| Q2 25 | $9.9M | $34.0M | ||
| Q1 25 | $-6.8M | $58.0M | ||
| Q4 24 | $-31.8M | $37.5M | ||
| Q3 24 | $-4.1M | $33.8M | ||
| Q2 24 | $2.0M | $38.4M | ||
| Q1 24 | $-3.9M | — |
| Q4 25 | 14.8% | 59.7% | ||
| Q3 25 | 14.6% | 59.5% | ||
| Q2 25 | 15.0% | 59.8% | ||
| Q1 25 | 13.0% | 58.4% | ||
| Q4 24 | 13.3% | 55.5% | ||
| Q3 24 | 12.5% | 54.2% | ||
| Q2 24 | 12.1% | 52.0% | ||
| Q1 24 | 10.7% | — |
| Q4 25 | 19.8% | 19.9% | ||
| Q3 25 | 19.9% | 17.9% | ||
| Q2 25 | 20.6% | 16.8% | ||
| Q1 25 | 19.0% | 21.6% | ||
| Q4 24 | 20.0% | 16.9% | ||
| Q3 24 | 19.6% | 15.0% | ||
| Q2 24 | 19.4% | 11.8% | ||
| Q1 24 | 18.2% | — |
| Q4 25 | 1.9% | 13.2% | ||
| Q3 25 | 10.5% | 11.8% | ||
| Q2 25 | 2.0% | 10.6% | ||
| Q1 25 | -1.4% | 17.5% | ||
| Q4 24 | -6.4% | 10.8% | ||
| Q3 24 | -0.9% | 9.8% | ||
| Q2 24 | 0.4% | 11.4% | ||
| Q1 24 | -0.9% | — |
| Q4 25 | $0.07 | $0.95 | ||
| Q3 25 | $0.33 | $0.81 | ||
| Q2 25 | $0.06 | $0.70 | ||
| Q1 25 | $-0.04 | $1.17 | ||
| Q4 24 | $-0.23 | $0.74 | ||
| Q3 24 | $-0.03 | $0.66 | ||
| Q2 24 | $0.01 | $0.74 | ||
| Q1 24 | $-0.04 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $363.4M |
| Total DebtLower is stronger | — | $1.2B |
| Stockholders' EquityBook value | $3.3B | $911.5M |
| Total Assets | $5.4B | $2.5B |
| Debt / EquityLower = less leverage | — | 1.34× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | $363.4M | ||
| Q3 25 | $147.4M | $296.4M | ||
| Q2 25 | $133.5M | $292.9M | ||
| Q1 25 | $86.1M | $306.8M | ||
| Q4 24 | $76.7M | $320.8M | ||
| Q3 24 | $67.8M | $299.3M | ||
| Q2 24 | $52.1M | $344.4M | ||
| Q1 24 | $77.0M | — |
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.3B | $911.5M | ||
| Q3 25 | $2.7B | $849.2M | ||
| Q2 25 | $2.4B | $882.3M | ||
| Q1 25 | $2.3B | $820.8M | ||
| Q4 24 | $2.3B | $906.9M | ||
| Q3 24 | $2.2B | $878.9M | ||
| Q2 24 | $1.9B | $905.4M | ||
| Q1 24 | $2.0B | — |
| Q4 25 | $5.4B | $2.5B | ||
| Q3 25 | $4.8B | $2.4B | ||
| Q2 25 | $4.5B | $2.5B | ||
| Q1 25 | $4.5B | $2.5B | ||
| Q4 24 | $4.5B | $2.5B | ||
| Q3 24 | $4.7B | $2.5B | ||
| Q2 24 | $4.6B | $2.5B | ||
| Q1 24 | $4.7B | — |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | — | 1.39× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $93.6M |
| Free Cash FlowOCF − Capex | — | $87.2M |
| FCF MarginFCF / Revenue | — | 25.7% |
| Capex IntensityCapex / Revenue | — | 1.9% |
| Cash ConversionOCF / Net Profit | 5.12× | 2.09× |
| TTM Free Cash FlowTrailing 4 quarters | — | $308.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $93.6M | ||
| Q3 25 | $107.2M | $111.3M | ||
| Q2 25 | $71.5M | $17.4M | ||
| Q1 25 | $60.6M | $116.6M | ||
| Q4 24 | $59.5M | $43.8M | ||
| Q3 24 | $63.1M | $48.8M | ||
| Q2 24 | $59.4M | $-27.4M | ||
| Q1 24 | $-6.0M | — |
| Q4 25 | — | $87.2M | ||
| Q3 25 | — | $106.3M | ||
| Q2 25 | — | $13.6M | ||
| Q1 25 | — | $100.9M | ||
| Q4 24 | — | $35.2M | ||
| Q3 24 | — | $39.4M | ||
| Q2 24 | — | $-33.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | 25.7% | ||
| Q3 25 | — | 32.5% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 30.5% | ||
| Q4 24 | — | 10.1% | ||
| Q3 24 | — | 11.4% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.9% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 4.7% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 1.7% | ||
| Q1 24 | — | — |
| Q4 25 | 5.12× | 2.09× | ||
| Q3 25 | 1.92× | 2.88× | ||
| Q2 25 | 7.21× | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | — | 1.17× | ||
| Q3 24 | — | 1.44× | ||
| Q2 24 | 30.02× | -0.71× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
